Warner Chilcott Co. v. Teva Pharmaceuticals USA, Inc.

FINDING OF FACT AND CONCLUSIONS OF LAW

HOCHBERG, District Judge:

This Opinion constitutes the Court’s findings of facts and conclusions of law pursuant to Federal Rule of Civil Procedure 52.

I. INTRODUCTION

Atelvia® — the osteoporosis drug covered by the challenged patents — purports to solve a problem experienced by patients who used earlier osteoporosis drugs: if ■the earlier drugs were taken with a meal, the active ingredient was captured by the calcium found in food molecules and was not absorbed into the body.1 When the medicine failed to enter the bloodstream, patients’ bones became…